Silencing of BCL11A gene expression by miR-137 or disruption of BCL11A-DNMT1 (DNA methyltransferase 1) interaction reduced the number of cancer stem cells and inhibited cancer development [7]. The gene discussed is BCL11A; the disease is cancer.